Health TrialsbyHealthPanel

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.

Participants needed: 140
Trial details
Age: 2-65Biological sex: AllType: ObservationalSponsor: SYSNAVUpdated: Sep 23, 2026Locations: 4
Eligibility criteria

b. Aged between 2 years old and < 17 years old at the time of consent (United Ki... [+6]

Subjects who have short stature condition other than ACH/HCH. [+8]

Read more
Status: Not yet recruiting

Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including functional capacity and cognitive assessments, as well as core scales assessments.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: SYSNAVUpdated: Apr 22, 2026Locations: 1
Eligibility criteria

Patients with extreme cognitive disorders that limit their understanding of the... [+6]

Read more
Status: Recruiting

Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)

Participants needed: 30
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: SYSNAVUpdated: Mar 23, 2026Locations: 1
Eligibility criteria

Age at inclusion between =18 and =65 years old [+10]

Participants with a relapse within the past 3 months before the inclusion [+6]

Read more